Core Scientific CORZ
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Core Scientific (CORZ) Core Market Data and Business Metrics
Latest Closing Price
$8.42Price-Earnings Ratio
-1.92Total Outstanding Shares
294.89 Million SharesDividend
No dividendSIC Description
Finance ServicesPrimary Exchange
NASDAQHeadquarters
838 Walker Road, Dover, DE, 19904
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 24,821,544 Shares | 1.56 | 3/14/2025 | 38,607,015 Shares |
| 13,837,049 Shares | 3.07 | 2/28/2025 | 42,491,025 Shares |
| 6,852,718 Shares | 6.27 | 2/14/2025 | 42,954,004 Shares |
| 16,035,401 Shares | 2.62 | 1/31/2025 | 42,005,221 Shares |
| 8,741,173 Shares | 4.86 | 1/15/2025 | 42,457,906 Shares |
| 9,974,828 Shares | 4.48 | 12/31/2024 | 44,669,764 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Investing Activities, Continuing | $-95.19 Million |
| Net Cash Flow From Operating Activities | $42.90 Million |
| Net Cash Flow, Continuing | $767.27 Million |
| Net Cash Flow From Financing Activities | $819.57 Million |
| Net Cash Flow From Financing Activities, Continuing | $819.57 Million |
| Net Cash Flow | $767.27 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit, Deferred | $0 |
| Net Income/Loss Available To Common Stockholders, Basic | $-1.12 Billion |
| Operating Expenses | $140.27 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $0 |
| Benefits Costs and Expenses | $1.82 Billion |
| Cost Of Revenue | $389.60 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $-1.32 Billion |
| Comprehensive Income/Loss Attributable To Parent | $-1.32 Billion |
| Other Comprehensive Income/Loss Attributable To Parent | $0 |
| Other Comprehensive Income/Loss | $-1.32 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Accounts Payable | $19.27 Million |
| Current Liabilities | $134.56 Million |
| Liabilities | $2.42 Billion |
| Equity Attributable To Noncontrolling Interest | $0 |
| Current Assets | $903.96 Million |
| Other Current Liabilities | $81.11 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||